Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for flt3 ligand protein (compound)
Most Correlated Studies
- CD34+ hematopoietic progenitor cell gene expression in response to different culture conditions
- Cytokine control of hematopoietic stem cell gene expression through STAT5A/B transcription factors
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
Most Relevant Literature
- Engineering and crystal structure of a monomeric FLT3 ligand variant.
- FLT3 Ligand Is Dispensable for the Final Stage of Type 1 Conventional Dendritic Cell Differentiation…
- Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendriti…
- Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate again…
- FL/GCSF/AMD3100-mobilized Hematopoietic Stem Cells Induce Mixed Chimerism With Nonmyeloablative Cond…
Most Relevant Clinical Trials
- FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer
- FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy
- TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia
- Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myel…
- flt3L in Treating Patients With Acute Myeloid Leukemia
